Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Main Authors: | Sergio Harari, Marc Humbert, Francesco Blasi, Harold R. Collard, Marco Matucci-Cerinic, Gerald Simonneau, Carlo Vancheri, Athol U. Wells, Vincent Cottin |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2015-09-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/24/137/375.full |
Similar Items
-
Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?
by: Andrei Seferian, et al.
Published: (2013-09-01) -
Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
by: Chiara Villa
Published: (2020-11-01) -
Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
by: Wei-Hsin Chung, et al.
Published: (2023-05-01) -
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
by: Balázs Horváth, et al.
Published: (2022-02-01) -
The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
by: Alexandra Agapidou, et al.
Published: (2016-05-01)